Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Poortmans

Showing results (131-140 of 258) with videos related to

Pageof 26
Sort By:
Eclinicalmedicine|January 25, 2021
What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of viewMaria Luisa Gasparri, Philip Poortmans, Maggie Banys-Paluchowski, et al.
JAMA Oncology|January 17, 2025
Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative ReviewIcro Meattini, Charlotte E Coles, Trine Tramm, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2012
EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facilityAlysa Fairchild, Edwin Aird, Paul A Fenton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2008
Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st centuryTom Budiharto, Elena Musat, Philip Poortmans, et al.
Clinical and Translational Radiation Oncology|March 1, 2024
Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy - Results from European and Latin American surveysMonica-Emila Chirilă, Fatjona Kraja, Gustavo Nader Marta, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2020
De-intensifying Radiation Therapy in HER-2 Positive Breast Cancer: To Boost or Not to Boost?Joseph Abi Jaoude, Majd Kayali, Evandro de Azambuja, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Defining a Leader Role curriculum for radiation oncology: A global Delphi consensus studySandra Turner, Matthew Seel, Theresa Trotter, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2023
Equity, Diversity, and Inclusion in Radiation Oncology: A Bibliometric Analysis and Critical ReviewPierfrancesco Franco, Francesca De Felice, Orit Kaidar-Person, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2008
The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelinesTheodore Girinsky, Lena Specht, Mithra Ghalibafian, et al.
Acta Oncologica (Stockholm, Sweden)|January 27, 2010
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)Oscar Matzinger, Irma Heimsoth, Philip Poortmans, et al.
Pageof 26

Showing results (131-140 of 258) with videos related to

Sort By:
Pageof 26
Eclinicalmedicine|January 25, 2021
What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of viewMaria Luisa Gasparri, Philip Poortmans, Maggie Banys-Paluchowski, et al.
JAMA Oncology|January 17, 2025
Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative ReviewIcro Meattini, Charlotte E Coles, Trine Tramm, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2012
EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facilityAlysa Fairchild, Edwin Aird, Paul A Fenton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2008
Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st centuryTom Budiharto, Elena Musat, Philip Poortmans, et al.
Clinical and Translational Radiation Oncology|March 1, 2024
Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy - Results from European and Latin American surveysMonica-Emila Chirilă, Fatjona Kraja, Gustavo Nader Marta, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2020
De-intensifying Radiation Therapy in HER-2 Positive Breast Cancer: To Boost or Not to Boost?Joseph Abi Jaoude, Majd Kayali, Evandro de Azambuja, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Defining a Leader Role curriculum for radiation oncology: A global Delphi consensus studySandra Turner, Matthew Seel, Theresa Trotter, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2023
Equity, Diversity, and Inclusion in Radiation Oncology: A Bibliometric Analysis and Critical ReviewPierfrancesco Franco, Francesca De Felice, Orit Kaidar-Person, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2008
The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelinesTheodore Girinsky, Lena Specht, Mithra Ghalibafian, et al.
Acta Oncologica (Stockholm, Sweden)|January 27, 2010
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)Oscar Matzinger, Irma Heimsoth, Philip Poortmans, et al.
Pageof 26